Peridol 1.5 mg (Haloperidol)

Adult dose

Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, Tourette syndrome (Gilles de la Tourette's syndrome): The initial dose of haloperidol is 1-15㎎ per day orally in 2-3 divided doses (up to 100㎎ may be administered in severe cases). Once a therapeutic response is achieved, gradually reduce the dose to the minimum effective maintenance dose. Adjust the dose as needed according to age and symptoms. For elderly or debilitated patients, the initial dose of haloperidol is 1-6mg per day orally in 2-3 divided doses.

Child dose

Age 14 years and older: The initial dose of haloperidol is 1-15㎎ per day orally in 2-3 divided doses (up to 100㎎ may be administered in severe cases). Once a therapeutic response is achieved, gradually reduce the dose to the minimum effective maintenance dose.

This medication may increase the risk of death in elderly patients with dementia, so it should be used with caution. There is a potential increased risk of cerebrovascular disease, requiring particular caution in patients at risk of stroke. As there may be a possibility of venous thromboembolism, risk factors for thrombosis should be checked and preventive measures taken before and during the use of this medication. This medication should not be administered to patients with hypersensitivity, comatose states, severe heart failure, Parkinson's disease, certain dementia diseases, bronchitis, or pregnant women. It should be administered with caution in patients with impaired liver or kidney function, cardiovascular disease, seizure disorders, thyroid disorders, and the elderly. Various side effects such as cardiac rhythm disturbances, blood pressure changes, muscle rigidity, and movement disorders may occur, necessitating immediate consultation with healthcare professionals if symptoms arise. Regular examinations of liver and kidney function, as well as blood status, should be performed during long-term use, with careful observation of the patient's condition. This medication may interact with other central nervous system depressants, antidepressants, heart medications, etc., so it is essential to inform healthcare professionals about any concurrent medications being taken. Pregnant or breastfeeding women should not use this medication, as adverse effects may occur in the fetus or newborn. It is advisable to avoid hazardous activities such as driving or operating machinery during the use of this medication. Serious side effects may occur in cases of overdose, so the dosage should be strictly adhered to, and immediate emergency treatment should be sought in case of abnormal symptoms.

Increased mortality, increased risk of cerebrovascular disease, venous thromboembolism, abnormal electrocardiogram, hypotension, hypertension, tachycardia, ventricular tachycardia, thrombosis, motor paralysis, severe muscle rigidity, dysphagia, sweating, fever, leukocytosis, elevated serum CPK, myoglobinuria, renal dysfunction, high fever, altered consciousness, dyspnea, circulatory collapse, dehydration symptoms, acute renal failure, acute muscular dystonia, ocular movement seizure, torticollis, trismus, Parkinsonian rigidity, tremor, akinesia, inability to sit upright, irreversible involuntary abnormal hypertonic motor disorder syndrome, hepatitis, jaundice, liver dysfunction, retinitis, cataract, accommodation disorder of the eye, blurred vision, corneal opacity, lens opacity, corneal pigmentation, edema, erythema, urticaria, exfoliative dermatitis, photosensitivity, anaphylactic reaction, anemia, leukocytosis, leukopenia, erythrocytopenia, agranulocytosis, loss of appetite, nausea, vomiting, constipation, diarrhea, intestinal paralysis, paralytic ileus, hyperprolactinemia, gynecomastia, galactorrhea, menstrual irregularities, changes in libido, hyperglycemia, hypoglycemia, weight gain, weight loss, hyponatremia, hypotonic hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, bronchospasm, laryngeal spasm, dyspnea, insomnia, anxiety, drowsiness, dizziness, headache, cephalalgia, anxiety, depression, hallucinations, agitation, thirst, nasal congestion, fatigue, urinary retention, fever, sweating, flushing, hypothermia

This medication is sensitive to light and should be stored in a container that prevents light exposure. Additionally, it is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round tablets

Package unit

1000 tablets/bottle